在非特应性重度哮喘患者中通过奥马珠单抗治疗实现疾病控制的真实世界研究。 - Suppr

Real-life study in non-atopic severe asthma patients achieving disease control by omalizumab treatment.

作者信息

Campo Paloma, Soto Campos Gregorio, Moreira Ana, Quirce Santiago, Padilla-Galo Alicia, Martínez-Moragón Eva, Mardones Aizea, Dávila Ignacio

机构信息

Allergy Unit, IBIMA-Regional University Hospital of Málaga, ARADyAL, Málaga, Spain.

Pneumology and Allergy Unit, University Hospital of Jerez, Cádiz, Spain.

出版信息

Allergy. 2021 Jun;76(6):1868-1872. doi: 10.1111/all.14668. Epub 2020 Dec 31.

DOI:10.1111/all.14668

PMID:33220106

Abstract

摘要

相似文献

Real-life study in non-atopic severe asthma patients achieving disease control by omalizumab treatment.在非特应性重度哮喘患者中通过奥马珠单抗治疗实现疾病控制的真实世界研究。

Allergy. 2021 Jun;76(6):1868-1872. doi: 10.1111/all.14668. Epub 2020 Dec 31.

[The effectiveness of target therapy in patients with severe allergic asthma].[靶向治疗在重度过敏性哮喘患者中的有效性]

Ter Arkh. 2019 Dec 15;91(12):57-62. doi: 10.26442/00403660.2019.12.000451.

Omalizumab: a treatment for severe asthma in real life?奥马珠单抗：现实生活中治疗重度哮喘的药物？

Rev Port Pneumol (2006). 2015 May-Jun;21(3):111-2. doi: 10.1016/j.rppnen.2015.04.002.

Different Skin Prick Test Sensitization Patterns Do Not Influence the Response to Omalizumab in Severe Asthma.不同的皮肤点刺试验致敏模式不影响重度哮喘患者对奥马珠单抗的反应。

J Investig Allergol Clin Immunol. 2017;27(6):388-391. doi: 10.18176/jiaci.0196.

Omalizumab could be effective in children with severe eosinophilic non-allergic asthma.奥马珠单抗可能对重度嗜酸性粒细胞性非过敏性哮喘患儿有效。

Pediatr Allergy Immunol. 2018 Feb;29(1):90-93. doi: 10.1111/pai.12813. Epub 2017 Nov 20.

Omalizumab discontinuation in children with severe allergic asthma: An observational real-life study.严重过敏性哮喘患儿停用奥马珠单抗：一项观察性真实世界研究。

Allergy. 2019 May;74(5):999-1003. doi: 10.1111/all.13678. Epub 2019 Jan 29.

[Omalizumab in children with uncontrolled asthma: a real-life study carried out in Colombia].[奥马珠单抗治疗儿童难治性哮喘：在哥伦比亚开展的一项真实世界研究]

Rev Alerg Mex. 2018 Jul-Sep;65(3):222-232. doi: 10.29262/ram.v65i3.510.

[Clinical experience with omalizumab in patients with severe asthma. Real-world data].[奥马珠单抗治疗重度哮喘患者的临床经验。真实世界数据]

Rev Alerg Mex. 2016 Jul-Sep;63(3):216-26. doi: 10.29262/ram.v63i3.144.

[The effectiveness of omalizumab in the control of severe uncontrolled asthma in Latin America. An exploratory systematic review and meta-analysis].[奥马珠单抗对拉丁美洲严重难治性哮喘的控制效果：一项探索性系统评价与荟萃分析]

Rev Alerg Mex. 2020 Jan-Mar;67(1):19-24. doi: 10.29262/ram.v67i1.701.

'Real-life' effectiveness studies of omalizumab in adult patients with severe allergic asthma: systematic review.奥马珠单抗治疗成人重度变应性哮喘的真实世界疗效研究：系统评价。

Allergy. 2016 May;71(5):593-610. doi: 10.1111/all.12815. Epub 2016 Feb 25.

引用本文的文献

The clinical and pathological histology efficacy of biological therapy for severe asthma with a phenotype of type 2 inflammation - systematic review.2型炎症表型重度哮喘生物治疗的临床及病理组织学疗效——系统评价

Front Immunol. 2025 Apr 15;16:1531986. doi: 10.3389/fimmu.2025.1531986. eCollection 2025.

Personalized Medicine in Severe Asthma: From Biomarkers to Biologics.严重哮喘的个体化医学：从生物标志物到生物制剂。

Int J Mol Sci. 2023 Dec 22;25(1):182. doi: 10.3390/ijms25010182.

Can omalizumab be an alternative treatment for non-atopic severe asthma? A real-life experience with omalizumab.奥马珠单抗可否作为非过敏性重症哮喘的替代疗法？奥马珠单抗的真实临床经验。

Tuberk Toraks. 2023 Mar;71(1):24-33. doi: 10.5578/tt.20239904.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Real-life study in non-atopic severe asthma patients achieving disease control by omalizumab treatment.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献